Cucurbitacin B, another derivative suppresses tumor growth in pancreatic cancer cells by inhibiting JAK/STAT pathway and synergistically increases antiproliferative effects of gemcitabine in vitro [109]. Here, SOAT1 is linked to neoplasm.